Propanc Biopharma Inc. (PPCB)
NasdaqCM: PPCB
· Precio en tiempo real · USD
1.22
+0.00 (0.00%)
Al cierre: Aug 14, 2026, 3:59 PM
1.22
+0.00%
Fuera de horario: 7:34 PM
Propanc Biopharma Inc. (PPCB) Stock Price, Analysis & Data
0.00% (1D)
| Precio de compra | 0.89 |
| Capitalización de mercado | 2.78M |
| Ingresos (TTM) | n/a |
| Beneficio neto (TTM) | -19.29M |
| Beta | 3.27 |
| EPS (TTM) | 570.5 |
| Ratio PER (TTM) | 0 |
| Adelante PE | n/a |
| P/B (TTM) | 0.11 |
| P/S (TTM) | n/a |
| Earnings Date | n/a |
| Precio de venta | 1.54 |
| Volumen | 39,410 |
| Volumen medio (20D) | 3,935,445 |
| Abierto | 1.21 |
| Anterior Cerrar | 1.22 |
| Rango del día | 1.20 - 1.29 |
| Rango de 52 semanas | 0.95 - 234.00 |
| analista | n/a |
| Precio objetivo | n/a |
| Dividendos | n/a |
| Fecha ex dividendo | n/a |
Acerca de PPCB
Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreemen...
Industria Biotechnology
Sector Healthcare
IPO Fecha Jan 7, 2013
Empleados 1
Bolsa de Valores NasdaqCM
Símbolo bursátil PPCB
Sitio web https://www.propanc.com
Desempeño financiero
En 2025, los ingresos de Propanc Biopharma fueron 0, un aumento de undefined% en comparación con 0 del año anterior. Las ganancias fueron -58.92M, un aumento de 3,136.6%.
Estados financieros